That women are second-class citizens of the medical research establishment is a claim much trumpeted. Hillary Rodham Clinton once remarked on the "appalling degree to which women were routinely excluded from major clinical trials of most illnesses." A recent report of the Commission on Civil Rights claimed that "women have been excluded from clinical trials for decades." Last June the Harvard Women's Health Watch proclaimed that "nearly all drug testing has been done on men."
But what we know is wrong. Last week the National Institutes of Health, which had stated in 1997 that "women were routinely excluded" from its research, issued a retraction of this claim. The Institutes' recognition of this error (made in two letters to a Rockville, Md.-based advocacy group called Men's Health America) is most welcome.
But don't expect the women's health lobby -- the network of public "offices of women's health" that exist on the state and federal levels, and the university-based "women's health centers" -- to admit it any time soon. For these groups must make women appear embattled and shortchanged if they are to gain government support, raise funds and justify themselves in the eyes of the public.
The NIH retraction comes a few months after the publication of a study by Curt Meinert and colleagues at Johns Hopkins University. Writing in the journal Controlled Clinical Trials, Mr. Meinert debunks an enduring feminist myth: that there is gender bias in medical research. His review of major medical journals in 1985, 1990 and 1995 found that female subjects outnumbered males at a rate of 13 to 1 across all cancer trials, with the vast bulk of the women participating in trials specifically for breast cancer. Yet the myth found its way into Al Gore's campaign platform: "Throughout my career I have fought for more research funds for those diseases so recently considered less important because they befell only women, such as breast cancer. . . . I pledge to you: women's...
Please join StudyMode to read the full document